000 01595 a2200421 4500
005 20250512225654.0
264 0 _c19830817
008 198308s 0 0 eng d
022 _a0008-543X
024 7 _a10.1002/1097-0142(19830801)52:3<435::aid-cncr2820520308>3.0.co;2-1
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAndrieu, J M
245 0 0 _aMenstrual cycle, pregnancies and offspring before and after MOPP therapy for Hodgkin's disease.
_h[electronic resource]
260 _bCancer
_cAug 1983
300 _a435-8 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAntineoplastic Agents
_xadministration & dosage
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
650 0 4 _aDrug Therapy, Combination
650 0 4 _aFemale
650 0 4 _aHodgkin Disease
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aMechlorethamine
_xadministration & dosage
650 0 4 _aMenstruation
_xdrug effects
650 0 4 _aMiddle Aged
650 0 4 _aParity
_xdrug effects
650 0 4 _aPrednisone
_xadministration & dosage
650 0 4 _aPregnancy
_xdrug effects
650 0 4 _aProcarbazine
_xadministration & dosage
650 0 4 _aProspective Studies
650 0 4 _aSurveys and Questionnaires
650 0 4 _aVincristine
_xadministration & dosage
700 1 _aOchoa-Molina, M E
773 0 _tCancer
_gvol. 52
_gno. 3
_gp. 435-8
856 4 0 _uhttps://doi.org/10.1002/1097-0142(19830801)52:3<435::aid-cncr2820520308>3.0.co;2-1
_zAvailable from publisher's website
999 _c6687830
_d6687830